IBM ACQUIRES This Company and 3 Dow Movers Making Headlines

International Business Machines Corp. (NYSE:IBM) reported on Monday that it will purchase Kenexa, which produces recruitment software, for $1.3 billion in a cash transaction. Kenexa shareholders will receive $46 per share, which is 42 percent above the close on Friday.

Don’t Miss: Apple Has More Retina Up Its Sleeve.

Intel Corporation (NASDAQ:INTC): Notebook panels prices have fallen because of slow demand from markets running up to the release of Windows 8 and also due to a lack of recovery in the economies of North America and Europe, according to industry sources to DigiTimes. DisplaySearch forecasts a price decrease of $1 with 13.1-, 14.0-, and 15.6-inch notebook panels by the end of the month.

Johnson & Johnson (NYSE:JNJ): Bayer Aktienges Ads (BAYRY) reported that a major subgroup evaluation from the Atlas ACS 2-TIMI 51 study of 7,817 patients suffering from ACS and a recent ST-segment elevation myocardial infarction, or STEMI, showed that oral anticoagulant Xarelto 2.5 mg twice daily, alongside standard antiplatelet therapy, gives a significant mortality benefit. The study indicated that adding rivaroxaban to standard antiplatelet therapy significantly decreased the composite primary efficacy endpoint of cardiovascular death, myocardial infarction or stroke compared to standard antiplatelet therapy by itself. Although the rates of TIMI major bleeding were increased with rivaroxaban, it did not increase the rate of fatal bleeding. In general, the addition of rivaroxaban 2.5 mg administered twice daily significantly reduced mortality, including cardiovascular death plus all cause death, when compared to standard therapy alone. Xarelto is co-developed by Johnson & Johnson and Bayer.

JPMorgan Chase & Co. (NYSE:JPM): Banks which face the inquiry for Libor manipulation might potentially be liable for tens of billions of dollars in claims from a slew of lawsuits in the United States, from insurers, cities, investors and lenders who will claim damages from the allegedly fudged rates, according to the Wall Street Journal.

Don’t Miss: Controversy: Should These Companies Pay MORE Taxes?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.